Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 02:08:15 UTC |
---|
Update Date | 2021-09-26 22:59:07 UTC |
---|
HMDB ID | HMDB0248693 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Ataprost |
---|
Description | 5-[4-(3-cyclopentyl-3-hydroxyprop-1-en-1-yl)-5-hydroxy-octahydropentalen-2-ylidene]pentanoic acid belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. Based on a literature review a significant number of articles have been published on 5-[4-(3-cyclopentyl-3-hydroxyprop-1-en-1-yl)-5-hydroxy-octahydropentalen-2-ylidene]pentanoic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). Ataprost is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Ataprost is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | OC(C=CC1C(O)CC2CC(CC12)=CCCCC(O)=O)C1CCCC1 InChI=1S/C21H32O4/c22-19(15-6-2-3-7-15)10-9-17-18-12-14(5-1-4-8-21(24)25)11-16(18)13-20(17)23/h5,9-10,15-20,22-23H,1-4,6-8,11-13H2,(H,24,25) |
---|
Synonyms | Value | Source |
---|
5-[4-(3-Cyclopentyl-3-hydroxyprop-1-en-1-yl)-5-hydroxy-octahydropentalen-2-ylidene]pentanoate | Generator | 15-Cyclopentyl-omega-pentanor-5(e)-carbacyclin | MeSH | Ataprost, 3as-(3aalpha,4alpha(1E,3R*),5beta,6aalpha)-isomer | MeSH |
|
---|
Chemical Formula | C21H32O4 |
---|
Average Molecular Weight | 348.483 |
---|
Monoisotopic Molecular Weight | 348.23005951 |
---|
IUPAC Name | 5-[4-(3-cyclopentyl-3-hydroxyprop-1-en-1-yl)-5-hydroxy-octahydropentalen-2-ylidene]pentanoic acid |
---|
Traditional Name | 5-[4-(3-cyclopentyl-3-hydroxyprop-1-en-1-yl)-5-hydroxy-hexahydro-1H-pentalen-2-ylidene]pentanoic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | OC(C=CC1C(O)CC2CC(CC12)=CCCCC(O)=O)C1CCCC1 |
---|
InChI Identifier | InChI=1S/C21H32O4/c22-19(15-6-2-3-7-15)10-9-17-18-12-14(5-1-4-8-21(24)25)11-16(18)13-20(17)23/h5,9-10,15-20,22-23H,1-4,6-8,11-13H2,(H,24,25) |
---|
InChI Key | DKLGLHQHLFISGJ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Fatty Acyls |
---|
Sub Class | Eicosanoids |
---|
Direct Parent | Prostaglandins and related compounds |
---|
Alternative Parents | |
---|
Substituents | - Prostaglandin skeleton
- Monoterpenoid
- Bicyclic monoterpenoid
- Medium-chain hydroxy acid
- Medium-chain fatty acid
- Hydroxy fatty acid
- Cyclic alcohol
- Secondary alcohol
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M-2H]- | 213.478 | 30932474 | DeepCCS | [M+Na]+ | 188.705 | 30932474 |
Predicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (Non-derivatized) - 70eV, Positive | splash10-00o0-4963000000-6e5dd093e8eb31dc9b40 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (TMS_3_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ataprost GC-MS (TBDMS_3_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ataprost 10V, Positive-QTOF | splash10-03e9-0039000000-e21e413ee14365d96c17 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ataprost 20V, Positive-QTOF | splash10-03fr-1196000000-12022a71715a5354a380 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ataprost 40V, Positive-QTOF | splash10-067l-9230000000-29d5c90363bca6ee9fd9 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ataprost 10V, Negative-QTOF | splash10-0002-0049000000-f7700ff4a93052e6b3f2 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ataprost 20V, Negative-QTOF | splash10-0002-0039000000-e05b6946d58d7c20f89a | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ataprost 40V, Negative-QTOF | splash10-0002-1069000000-1a9cc2f1432359b3c3f9 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|